CERRITOS, Calif., June 09, 2023 (GLOBE NEWSWIRE) — The Oncology Institute (NASDAQ: TOI), has announced a non-exclusive partnership with Massive Bio, a leader in leveraging …
Publicly traded leader in value-based oncology care raises standards in patient safety CERRITOS, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: …
SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) — The Oncology Institute of Hope & Innovation (NASDAQ: TOI), one of the largest value-based community oncology groups …
Article written by Tara Bannow via Modern Healthcare The first publicly traded oncology specialist debuted on the stock market this week following its merger with …
NEW YORK and LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) — The Oncology Institute (“TOI” or “The Company”), the U.S. market leader in value-based oncology …
The Oncology Institute recently welcomed its 150,000th patient since its founding in August 2007 It is fitting that this milestone was reached during Breast Cancer …
© 2022 The Oncology Institute of Hope and Innovation. All rights reserved.